Deal snapshot: AbbVie to Acquire Mitokinin for USD 110m.

MANews-(C)2009-2023

US-based AbbVie (NYSE: ABBV) has exercised its exclusive right and completed the acquisition of US-based discovery-stage biotechnology company Mitokinin, the company said.

Under the terms of the agreement, AbbVie will pay Mitokinin shareholders...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT